InsiderSignal.AI

InsiderSignal.ai

ORGO - Organogenesis Holdings Inc.

Insider Purchase by Nussdorf Glenn H (Dir, 10%)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

9 months ago, Nussdorf Glenn H, serving as Dir, 10% owner at Organogenesis Holdings Inc. (ORGO), purchased 358,495 shares at $3.06 per share, for a total transaction value of $1,096,039.00. Following this transaction, Nussdorf Glenn H now holds 12,248,560 shares of ORGO.

This purchase represents a 3.00% increase in Nussdorf Glenn H's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, May 14, 2025 and publicly disclosed via SEC Form 4 filing on Monday, November 3, 2025, 173 days after the trade was made.

Organogenesis Holdings Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Nussdorf Glenn H

Dir, 10%

Glenn H. Nussdorf is a 70-year-old business executive serving as Director at Organogenesis Holdings Inc. (ORGO) since 2003. He is not classified as an independent director and holds a significant beneficial ownership stake of approximately 9.4% to 11.7 million shares, valued at around $48 million as of late 2025, making him a 10% owner.[[1]](https://fintool.com/app/research/companies/ORGO/people/glenn-h-nussdorf)[[3]](https://www.gurufocus.com/insider/119392/glenn-h-nussdorf) Nussdorf brings expertise as Chief Executive Officer of Quality King Distributors, Inc. and its subsidiary QK Healthcare, Inc. since 1999, focusing on distribution in health and beauty care (HBC) and prescription products, and has been a director and major stockholder at Parlux Holdings, Inc. since 2017.[[1]](https://fintool.com/app/research/companies/ORGO/people/glenn-h-nussdorf) Nussdorf has been active in recent insider trading at ORGO, including selling 306,300 shares for $1.59 million between November 24-26, 2025, and 200,000 shares on December 16, 2025.[[2]](https://www.investing.com/news/insider-trading-news/organogenesis-director-nussdorf-sells-159-million-in-shares-93CH-4380708)[[4]](https://www.tradingview.com/news/tradingview:3b127ec01f7d0:0-organogenesis-holdings-director-glenn-h-nussdorf-sells-200-000-shares/) He maintains strong board attendance (≥75% in 2024) but is involved in related-party transactions, such as ORGO leasing facilities from entities he controls.[[1]](https://fintool.com/app/research/companies/ORGO/people/glenn-h-nussdorf) Previously part of a significant stockholder group that influenced governance until its agreement terminated on March 10, 2025, his long tenure aligns shareholder interests through substantial ownership.[[1]](https://fintool.com/app/research/companies/ORGO/people/glenn-h-nussdorf)[[3]](https://www.gurufocus.com/insider/119392/glenn-h-nussdorf)

View full insider profile →

Trade Price

$3.06

Quantity

358,495

Total Value

$1,096,039.00

Shares Owned

12,248,560

Trade Date

Wednesday, May 14, 2025

284 days ago

SEC Filing Date

Monday, November 3, 2025

Filed 173 days after trade

HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

About Organogenesis Holdings Inc.

Company Overview

No company information available
View news mentioning ORGO

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/1050620

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime